Procept Biorobotics
PRCT
257 hedge funds and large institutions have $1.4B invested in Procept Biorobotics in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 98 increasing their positions, 67 reducing their positions, and 46 closing their positions.
460% more call options, than puts
Call options by funds: $33.3M | Put options by funds: $5.95M
46% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 67
2% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 46
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.56% less ownership
Funds ownership: 100.52% → 98.96% (-1.6%)
2% less funds holding
Funds holding: 263 → 257 (-6)
21% less capital invested
Capital invested by funds: $1.77B → $1.4B (-$370M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$31.8M |
| 2 |
CC
Chicago Capital
Chicago,
Illinois
|
+$27.3M |
| 3 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$24.4M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$24.3M |
| 5 |
M
Mirova
Paris,
France
|
+$20.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$91.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$89.9M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$42.5M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$15.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.2M |
PRCT Hedge Fund Activity: Q1 2026 in Review
257 of the 8,186 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q1 2026, worth a combined $1.4B — down 21% from $1.77B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new PRCT positions and 46 closed out — a net gain of 1 holder — while 98 added to existing stakes and 67 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $31.8M. The largest seller was AllianceBernstein, cutting an estimated $91.3M.
- 257 institutional investors held Procept Biorobotics (PRCT) as of Q1 2026, down from 263 in Q4 2025.
- Funds reported $1.4B of Procept Biorobotics stock for Q1 2026, down 21% quarter-over-quarter.
- 47 funds opened new Procept Biorobotics positions in Q1 2026 and 46 closed out, a net change of +1 holder.
- The largest Procept Biorobotics buyer in Q1 2026 was Point72 Asset Management, an estimated $31.8M added.
- The largest Procept Biorobotics seller in Q1 2026 was AllianceBernstein, an estimated $91.3M sold.
Based on aggregated 13F filings for Q1 2026.